ERCC1 and non-small cell lung carcinoma: It has been demonstrated in several clinical studies that ERCC1 messenger RNA expression in various types of cancer, including ovarian, colorectal, gastric and esophageal cancer, as well as non-small cell lung cancer (NSCLC), is correlated with clinical resistance to platinum agents (20–23).